Deals channel feed

Cal­lid­i­tas’ rare dis­ease drug draws $1B+ buy­out of­fer from Japan­ese buy­er

11 months ago

BioN­Tech dou­bles down on ADC part­ner MediLink in new $1.8B biobucks pact

11 months ago
Startups
China

Cy­to­ki­net­ics CEO de­fends Roy­al­ty Phar­ma deal: 'That nar­ra­tive was hi­jacked'

11 months ago

Ex­clu­sive: Se­nior pri­ma­ry care start­up Gath­er Health has raised $16M in a new round

11 months ago
Health Tech

As­traZeneca taps more Chi­na-de­rived tech with $19M can­cer deal for Nona an­ti­bod­ies

11 months ago
R&D

Re­NA­gade is ac­quired by RNA ri­val a year af­ter megaround-backed launch

11 months ago
Cell/Gene Tx

Mer­ck KGaA makes $600M bet to boost man­u­fac­tur­ing for vi­ral vec­tors

11 months ago
Cell/Gene Tx
Manufacturing

Bio­gen makes $1.15B buy for ARCH's HI-Bio to ex­pand im­munol­o­gy pipeline

11 months ago

Boehringer In­gel­heim, OSE Im­munother­a­peu­tics ex­pand part­ner­ship be­yond can­cer

11 months ago

Sanofi, Ope­nAI, For­ma­tion Bio an­nounce AI drug de­vel­op­ment part­ner­ship

11 months ago
R&D
AI

Lil­ly makes an­oth­er ra­dio­phar­ma move in col­lab­o­ra­tion with Ak­tis On­col­o­gy

11 months ago
Startups

Health plan start­up Cen­ti­vo ac­quires pri­ma­ry care op­er­a­tor Eden Health

11 months ago
Startups
Health Tech

Q&A: FTC’s top health­care en­forcer on phar­ma M&A, com­pa­ny growth and PBMs

12 months ago
Pharma
FDA+

Eras­ca re­vamps pipeline, lay­ing off staff as it li­cens­es can­cer drugs from Chi­na and nabs $160M

12 months ago
R&D

GSK plans to sell off re­main­ing stake in con­sumer spin­out Ha­le­on

12 months ago
Pharma

Roche was in 'ad­vanced' talks to out-li­cense its An­gel­man syn­drome drug, but po­ten­tial part­ner with­drew

12 months ago
R&D
Pharma

J&J makes small I&I ac­qui­si­tion to en­ter com­pet­i­tive IL-13, TSLP are­na

12 months ago
R&D

BeiGene looks at new part­ner­ships, with a full can­cer pipeline and grow­ing foot­print

12 months ago
China
Pharma

Up­dat­ed: Black­stone com­mits $300M to a for­mer Mer­ck an­ti­body for asth­ma, COPD

12 months ago
Financing

Ex­clu­sive: Har­vard start­up rais­es $26M, strikes three phar­ma part­ner­ships for AI an­ti­body de­sign

12 months ago
AI

Ab­b­Vie goes deep­er in­to neu­ro­science with col­lab­o­ra­tion worth as much as $2B

12 months ago
Pharma

Take­da bets $100M up­front on AC Im­mune's an­ti-amy­loid Alzheimer's vac­cine

12 months ago
Pharma

Sanofi buys ex-US rights to Ful­crum's Phase 3 rare neu­ro­mus­cu­lar drug

12 months ago
Pharma

Sanofi grabs a share of No­vavax's Covid vac­cine for $500M, eye­ing com­mer­cial­iza­tion, flu com­bi­na­tion

Last year
Pharma
Coronavirus
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times